Angiodynamics appoints richard c. rosenzweig senior vice president, general counsel and secretary, promotes juan carlos serna to senior vice president, scientific & clinical affairs

Latham, n.y.--(business wire)--angiodynamics, inc. (nasdaq: ango), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that it has appointed richard c. rosenzweig as senior vice president, general counsel, effective january 31, 2021. mr. rosenzweig will also serve as corporate secretary to the angiodynamics board of directors. mr. rosenzweig succeeds stephen trowbridge who has served as executive vi
ANGO Ratings Summary
ANGO Quant Ranking